Status:
RECRUITING
Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
COVID-19 Infection
Hematopoietic and Lymphoid Cell Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This study investigates the well-being and health-related quality of life in cancer patients and survivors during the COVID-19 pandemic. Using questionnaires may help researchers gain an understanding...
Detailed Description
PRIMARY OBJECTIVES: I. Assess experiences during the coronavirus disease 2019 (COVID-19) pandemic (e.g., exposure, risk factors, testing, isolation, seropositivity, hospitalization, loss of family or...
Eligibility Criteria
Inclusion
- MD Anderson active patient (visit within past 5 years)
- ICD-10 confirmed cancer diagnosis
- Documentation of being alive per the cancer registry
- Patients who have signed consent for one of the following protocols: PA14-0241 or LAB03-0320
- Has an active email address and/or can be contacted via MyChart
- English or Spanish speaker
Exclusion
- Non-active patient (i.e., no visit within past 5 years)
- Language other than English or Spanish
- Patients who have previously consented to the following protocols: 2012-0112, 2009-0976, 2005-0035, or PA15-0336, because they will be contacted through separate IRB protocols to complete this same survey
Key Trial Info
Start Date :
June 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2027
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT04500600
Start Date
June 11 2020
End Date
April 30 2027
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030